Epstein-barr virus, the immune system, and associated diseases

Frontiers in Microbiology

Volumn 2, Issue JAN, 2011, Pages

  Chen, Mei Ru ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Autoimmune disease; Epstein Barr virus; Immune system

Indexed keywords

EID: 84859040020     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2011.00005     Document Type: Article

References (37)

1. Ascherio, A., and Munger, K. L. (2007). Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann. Neurol. 61, 288-299.
2. Azakami, K., Sato, T., Araya, N., Utsunomiya, A., Kubota, R., Suzuki, K., Hasegawa, D., Izumi, T., Fujita, H., Aratani, S., Fujii, R., Yagishita, N., Kamijuku, H., Kanekura, T., Seino, K., Nishioka, K., Nakajima, T., and Yamano, Y. (2009). Severe loss of invariant NKT cells exhibiting anti-HTLV-1 activity in patients with HTLV-1-associated disorders. Blood 114, 3208-3215.
3. Berzofsky, J. A., and Terabe, M. (2008). NKT cells in tumor immunity: opposing subsets define a new immunoregulatory axis. J. Immunol. 180, 3627-3635.
4. Brady, G., Macarthur, G. J., and Farrell, P. J. (2008). Epstein-Barr virus and Burkitt lymphoma. Postgrad. Med. J. 84, 372-377.
5. Caldwell, R. G., Wilson, J. B., Anderson, S. J., and Longnecker, R. (1998). Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals. Immunity 9, 405-411.
6. Casiraghi, C., Dorovini-Zis, K., and Horwitz, M. S. (2011). Epstein-Barr virus infection of human brain microvessel endothelial cells: a novel role in multiple sclerosis. J. Neuroimmunol. 230, 173-177.
7. Compston, A., and Coles, A. (2008). Multiple sclerosis. Lancet 372, 1502-1517.
8. Gires, O., Zimber-Strobl, U., Gonnella, R., Ueffing, M., Marschall, G., Zeidler, R., Pich, D., and Hammerschmidt, W. (1997). Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule. EMBO J. 16, 6131-6140.
9. Godfrey, D. I., Stankovic, S., and Baxter, A. G. (2010). Raising the NKT cell family. Nat. Immunol. 11, 197-206.
10. Harris, N. L., Jaffe, E. S., Diebold, J., Flandrin, G., Muller-Hermelink, H.K., Vardiman, J., Lister, T. A., and Bloomfield, C. D. (1999). The world health organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the clinical advisory committee meeting, airlie house, Virginia, November, 1997. Ann. Oncol. 10, 1419-1432.
11. He, Y., Xiao, R., Ji, X., Li, L., Chen, L., Xiong, J., Xiao, W., Wang, Y., Zhang, L., Zhou, R., Tan, X., Bi, Y., Jiang, Y. P., Jin, Y., and Tan, J. (2010). EBV promotes human CD8 NKT cell development. PLoS Pathog. 6, e1000915. doi: 10.1371/journal.ppat.1000915
12. Hochberg, D., Middeldorp, J. M., Catalina, M., Sullivan, J. L., Luzuriaga, K., and Thorley-Lawson, D. A. (2004). Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo. Proc. Natl. Acad. Sci. U.S.A. 101, 239-244.
13. James, J. A., Neas, B. R., Moser, K. L., Hall, T., Bruner, G. R., Sestak, A. L., and Harley, J. B. (2001). Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure. Arthritis Rheum. 44, 1122-1126.
14. Ji, Q., Perchellet, A., and Goverman, J. M. (2010). Viral infection triggers central nervous system autoimmunity via activation of CD8? T cells expressing dual TCRs. Nat. Immunol. 11, 628-634.
15. Kapatai, G., and Murray, P. (2007). Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma. J. Clin. Pathol. 60, 1342-1349.
16. Kuppers, R., Rajewsky, K., Zhao, M., Simons, G., Laumann, R., Fischer, R., and Hansmann, M. L. (1994). Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc. Natl. Acad. Sci. U.S.A. 91, 10962-10966.
17. Kutok, J. L., and Wang, F. (2006). Spectrum of Epstein-Barr virus-associated diseases. Annu. Rev. Pathol. 1, 375-404.
18. Levin, L. I., Munger, K. L., Rubertone, M. V., Peck, C. A., Lennette, E. T., Spiegelman, D., and Ascherio, A. (2005). Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. JAMA 293, 2496-2500.
19. Lin, Y., Roberts, T. J., Wang, C. R., Cho, S., and Brutkiewicz, R. R. (2005). Longterm loss of canonical NKT cells following an acute virus infection. Eur. J. Immunol. 35, 879-889.
20. Ling, P. D., Hsieh, J. J., Ruf, I. K., Rawlins, D. R., and Hayward, S. D. (1994). EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1. J. Virol. 68, 5375-5383.
21. Lunemann, J. D., and Munz, C. (2009). EBV in MS: guilty by association? Trends Immunol. 30, 243-248.
22. Muramatsu, M., Kinoshita, K., Fagarasan, S., Yamada, S., Shinkai, Y., and Honjo, T. (2000). Class switch recombination and hypermutation require activationinduced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102, 553-563.
23. Pasqualucci, L., Bhagat, G., Jankovic, M., Compagno, M., Smith, P., Muramatsu, M., Honjo, T., Morse, H. C. III, Nussenzweig, M. C., and Dalla-Favera, R. (2008). AID is required for germinal center-derived lymphomagenesis. Nat. Genet. 40, 108-112.
24. Poole, B. D., Scofield, R. H., Harley, J. B., and James, J. A. (2006). Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus. Autoimmunity 39, 63-70.
25. Ransohoff, R. M. (2010). Turning over the chance card on MS susceptibility. Nat. Immunol. 11, 570-572.
26. Serafini, B., Rosicarelli, B., Franciotta, D., Magliozzi, R., Reynolds, R., Cinque, P., Andreoni, L., Trivedi, P., Salvetti, M., Faggioni, A., and Aloisi, F. (2007). Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J. Exp. Med. 204, 2899-2912.
27. Serafini, B., Severa, M., Columba-Cabezas, S., Rosicarelli, B., Veroni, C., Chiappetta, G., Magliozzi, R., Reynolds, R., Coccia, E. M., and Aloisi, F. (2010). Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation. J. Neuropathol. Exp. Neurol. 69, 677-693.
28. Thorley-Lawson, D. A. (2001). Epstein-Barr virus: exploiting the immune system. Nat. Rev. Immunol. 1, 75-82.
29. Thorley-Lawson, D. A., and Allday, M. J. (2008). The curious case of the tumour virus: 50 years of Burkitt's lymphoma. Nat. Rev. Microbiol. 6, 913-924.
30. Thorley-Lawson, D. A., and Gross, A. (2004). Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N. Engl. J. Med. 350, 1328-1337.
31. Thorley-Lawson, D. A., and Mann, K. P. (1985). Early events in Epstein-Barr virus infection provide a model for B cell activation. J. Exp. Med. 162, 45-59.
32. Toussirot, E., and Roudier, J. (2008). Epstein-Barr virus in autoimmune diseases. Best Pract. Res. Clin. Rheumatol. 22, 883-896.
33. Vaughan, J. H., Valbracht, J. R., Nguyen, M. D., Handley, H. H., Smith, R. S., Patrick, K., and Rhodes, G. H. (1995). Epstein-Barr virus-induced autoimmune responses. I. Immunoglobulin M autoantibodies to proteins mimicking and not mimicking Epstein-Barr virus nuclear antigen-1. J. Clin. Invest. 95, 1306-1315.
34. Xiao, W., Li, L., Zhou, R., Xiao, R., Wang, Y., Ji, X., Wu, M., Wang, L., Huang, W., Zheng, X., Tan, X., Chen, L., Xiong, T., Xiong, J., Jin, Y., Tan, J., and He, Y. (2009). EBV-induced human CD8(?) NKT cells synergise CD4(?) NKT cells suppressing EBV-associated tumours upon induction of Th1-bias. Cell. Mol. Immunol. 6, 367-379.
35. Yates, J. L., Warren, N., and Sugden, B. (1985). Stable replication of plasmidsderived from Epstein-Barr virus in various mammalian cells. Nature 313, 812-815.
36. Young, L. S., and Rickinson, A. B. (2004). Epstein-Barr virus: 40 years on. Nat. Rev. Cancer 4, 757-768.
37. Yuling, H., Ruijing, X., Li, L., Xiang, J., Rui, Z., Yujuan, W., Lijun, Z., Chunxian, D., Xinti, T., Wei, X., Lang, C., Yanping, J., Tao, X., Mengjun, W., Jie, X.,Youxin, J., and Jinquan, T. (2009). EBV-induced human CD8? NKT cells suppress tumorigenesis by EBVassociated malignancies. Cancer Res. 69, 7935-7944.